Schizophrenia Research
Volume 49, Issue 3 , Pages 243-251, 30 April 2001

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

  • Malcolm Peet

      Affiliations

    • Academic Department of Psychiatry, Northern General Hospital, The Longley Centre, Norwood Grange Drive, Sheffield S5 7JT, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-114-2261509; fax: +44-114-2261522
    • ,
  • Jan Brind

      Affiliations

    • Academic Department of Psychiatry, Northern General Hospital, The Longley Centre, Norwood Grange Drive, Sheffield S5 7JT, UK
    • ,
  • C.N. Ramchand

      Affiliations

    • Academic Department of Psychiatry, Northern General Hospital, The Longley Centre, Norwood Grange Drive, Sheffield S5 7JT, UK
    • ,
  • Sandeep Shah

      Affiliations

    • Department of Psychiatry, S.S.G. Hospital and Medical College, M.S. University, Baroda, India
    • ,
  • G.K. Vankar

      Affiliations

    • Department of Psychiatry, S.S.G. Hospital and Medical College, M.S. University, Baroda, India

Received 28 March 2000; accepted 9 May 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-9964(00)00083-9

Schizophrenia Research
Volume 49, Issue 3 , Pages 243-251, 30 April 2001

Article Tools

* Image Usage & Resolution